Table of Contents
ISRN Allergy
Volume 2011 (2011), Article ID 792613, 6 pages
http://dx.doi.org/10.5402/2011/792613
Research Article

Subjects in a Population Study with High Levels of FENO Have Associated Eosinophil Airway Inflammation

1Departments of Allergology and Respiratory Medicine, Sahlgrenska University Hospital, 413 45 Göteborg, Sweden
2Departments of Occupational and Environmental Medicine, Sahlgrenska University Hospital, 413 45 Göteborg, Sweden

Received 16 December 2010; Accepted 19 January 2011

Academic Editors: S. Lau and S. Loukides

Copyright © 2011 Gerdt C. Riise et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. N. R. Payne, “Nitric oxide in allergic airway inflammation,” Current Opinion in Allergy and Clinical Immunology, vol. 3, no. 2, pp. 133–137, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Mattes, K. Storm Van's Gravesande, U. Reining et al., “NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma,” European Respiratory Journal, vol. 13, no. 6, pp. 1391–1395, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jatakanon, S. Lim, S. A. Kharitonov, K. F. Chung, and P. J. Barnes, “Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma,” Thorax, vol. 53, no. 2, pp. 91–95, 1998. View at Google Scholar · View at Scopus
  4. K. Alving, E. Weitzberg, and J. M. Lundberg, “Increased amount of nitric oxide in exhaled air of asthmatics,” European Respiratory Journal, vol. 6, no. 9, pp. 1368–1370, 1993. View at Google Scholar · View at Scopus
  5. L. J. Dupont, M. G. Demedts, and G. M. Verleden, “Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma,” Chest, vol. 123, no. 3, pp. 751–756, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. D. Smith, J. O. Cowan, S. Filsell et al., “Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 4, pp. 473–478, 2004. View at Google Scholar · View at Scopus
  7. J. M. Sippel, W. E. Holden, S. A. Tilles et al., “Exhaled nitric oxide levels correlate with measures of disease control in asthma,” Journal of Allergy and Clinical Immunology, vol. 106, no. 4, pp. 645–650, 2000. View at Google Scholar · View at Scopus
  8. R. G. Stirling, S. A. Kharitonov, D. Campbell et al., “Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids,” Thorax, vol. 53, no. 12, pp. 1030–1034, 1998. View at Google Scholar
  9. A. M. Henriksen, M. Sue-Chu, T. Lingaas Holmen, A. Langhammer, and L. Bjermer, “Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness,” European Respiratory Journal, vol. 13, no. 2, pp. 301–306, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. L. M. van den Toorn, J. B. Prins, J. C. de Jongste et al., “Benefit from anti-inflammatory treatment during clinical remission of atopic asthma,” Respiratory Medicine, vol. 99, no. 6, pp. 779–787, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. C. Olin, A. Rosengren, D. S. Thelle, L. Lissner, B. Bake, and K. Torén, “Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample,” Chest, vol. 130, no. 5, pp. 1319–1325, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Svensson, A. C. Olin, M. Lärstad, G. Ljungkvist, and K. Torén, “Determination of hydrogen peroxide in exhaled breath condensate by flow injection analysis with fluorescence detection,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 809, no. 2, pp. 199–203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Lärstad, G. Ljungkvist, A. C. Olin, and K. Torén, “Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 766, no. 1, pp. 107–114, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Lärstad, A. S. Söderling, K. Caidahl, and A. C. Olin, “Selective quantification of free 3-nitrotyrosine in exhaled breath condensate in asthma using gas chromatography/tandem mass spectrometry,” Nitric Oxide, vol. 13, no. 2, pp. 134–144, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Hanazawa, S. A. Kharitonov, and P. J. Barnes, “Increased nitrotyrosine in exhaled breath condensate of patients with asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, part 1, pp. 1273–1276, 2000. View at Google Scholar · View at Scopus
  16. C. Janson, J. Anto, P. Burney et al., “The European community respiratory health survey: what are the main results so far?” European Respiratory Journal, vol. 18, no. 3, pp. 598–611, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Chinn, D. Jarvis, C. M. Luczynska et al., “An increase in bronchial responsiveness is associated with continuing or restarting smoking,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 8, pp. 956–961, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Sunyer, D. Jarvis, J. Pekkanen et al., “Geographic variations in the effect of atopy on asthma in the European Community Respiratory Health Study,” Journal of Allergy and Clinical Immunology, vol. 114, no. 5, pp. 1033–1039, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. “Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 2104–2117, 1999.
  20. M. L. Seymour, R. A. K. Sabina, D. Åberg et al., “Leukotriene and prostanoid pathway enzymes in bronchial biopsies of seasonal allergic asthmatics,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 11, pp. 2051–2056, 2001. View at Google Scholar · View at Scopus
  21. A. H. Henriksen, T. Lingaas-Holmen, M. Sue-Chu, and L. Bjermer, “Combined use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma in a large population survey,” European Respiratory Journal, vol. 15, no. 5, pp. 849–855, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. V. J. Erpenbeck, R. A. Jörres, M. Discher et al., “Local nitric oxide levels reflect the degree of allergic airway inflammation after segmental allergen challenge in asthmatics,” Nitric Oxide, vol. 13, no. 2, pp. 125–133, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. D. N. R. Payne, I. M. Adcock, N. M. Wilson, T. Oates, M. Scallan, and A. Bush, “Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 8, part 1, pp. 1376–1381, 2001. View at Google Scholar
  24. T. J. Warke, P. S. Fitch, V. Brown et al., “Exhaled nitric oxide correlates with airway eosinophils in childhood asthma,” Thorax, vol. 57, no. 5, pp. 383–387, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. C. E. Brightling, F. A. Symon, S. S. Birring, P. Bradding, A. J. Wardlaw, and I. D. Pavord, “Comparison of airway immunopathology of eosinophilic bronchitis and asthma,” Thorax, vol. 58, no. 6, pp. 528–532, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Lemiere, “Induced sputum and exhaled nitric oxide as noninvasive markers of airway inflammation from work exposures,” Current Opinion in Allergy and Clinical Immunology, vol. 7, no. 2, pp. 133–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Lim, A. Jatakanon, S. Meah, T. Oates, K. F. Chung, and P. J. Barnes, “Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma,” Thorax, vol. 55, no. 3, pp. 184–188, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Berry, D. E. Shaw, R. H. Green, C. E. Brightling, A. J. Wardlaw, and I. D. Pavord, “The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma,” Clinical and Experimental Allergy, vol. 35, no. 9, pp. 1175–1179, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Caramori and A. Papi, “Oxidants and asthma,” Thorax, vol. 59, no. 2, pp. 170–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. R. M. Effros, K. W. Hoagland, M. Bosbous et al., “Dilution of respiratory solutes in exhaled condensates,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 663–669, 2002. View at Google Scholar · View at Scopus